Sign Up to like & get
recommendations!
1
Published in 2022 at "Anti-cancer agents in medicinal chemistry"
DOI: 10.2174/1871520622666220520093837
Abstract: BACKGROUND Non-small cell lung cancer (NSCLC) accounts for about 80% of lung cancers. Cisplatin is a broad-spectrum anti-cancer drug and is often used in combination with other drugs. Research suggests that dendrobine, a pyrrolizidine derivative…
read more here.
Keywords:
effect;
effect dendrobine;
treatment;
cisplatin ... See more keywords